Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsCombined Modality TherapyTransplantation, HomologousGraft vs Host DiseaseBone Marrow PurgingWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsBone and BonesHematopoietic Stem Cell TransplantationLeukemiaCyclophosphamideTransplantation ConditioningAnemia, AplasticHematopoietic Stem CellsLymphoma, Non-HodgkinBusulfanGraft SurvivalTissue DonorsBone Marrow DiseasesLeukemia, Myeloid, AcuteCarmustineTransplantation ChimeraRecurrenceTreatment OutcomeHistocompatibility TestingRemission InductionHematopoiesisHistocompatibilityPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsTime FactorsMelphalanTransplantation, IsogeneicColony-Forming Units AssayImmunosuppressive AgentsHodgkin DiseaseLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationBone RemodelingKidney TransplantationSurvival AnalysisImmunosuppressionMice, Inbred C57BLEtoposideBone Marrow NeoplasmsCytomegalovirus InfectionsAcute DiseaseRadiation ChimeraLiver TransplantationStem Cell TransplantationGraft RejectionRetrospective StudiesHematologic DiseasesHepatic Veno-Occlusive DiseaseActuarial AnalysisCyclosporineCytarabineMyelodysplastic SyndromesFollow-Up StudiesT-LymphocytesSurvival RateLymphomaLymphocyte DepletionGraft vs Host ReactionDisease-Free SurvivalBone DensityLeukocyte CountMultiple MyelomaHLA AntigensGranulocyte Colony-Stimulating FactorOpportunistic InfectionsThiotepaImmunocompromised HostCell DifferentiationLeukocyte TransfusionNuclear FamilySalvage TherapyAntigens, CD34Bone ResorptionChimeraPrognosisTransplantation ImmunologyFatal OutcomeFlow CytometryLymphocyte TransfusionSevere Combined ImmunodeficiencyBone TransplantationGranulocytesHeart TransplantationCells, CulturedDrug EvaluationVincristineAntibodies, MonoclonalProspective StudiesCell SeparationPolymerase Chain Reaction